Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

348 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hormonal perturbations in patients with testicular cancer treated with cisplatin.
LeBlanc GA, Kantoff PW, Ng SF, Frei E 3rd, Waxman DJ. LeBlanc GA, et al. Among authors: waxman dj. Cancer. 1992 May 1;69(9):2306-10. doi: 10.1002/1097-0142(19920501)69:9<2306::aid-cncr2820690917>3.0.co;2-f. Cancer. 1992. PMID: 1562977
Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies.
Frei E 3rd, Holden SA, Gonin R, Waxman DJ, Teicher BA. Frei E 3rd, et al. Among authors: waxman dj. Cancer Chemother Pharmacol. 1993;33(2):113-22. doi: 10.1007/BF00685328. Cancer Chemother Pharmacol. 1993. PMID: 8261570
Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK, Waxman DJ. Chang TK, et al. Among authors: waxman dj. Cancer Res. 1993 Jun 1;53(11):2490-7. Cancer Res. 1993. PMID: 8495410
Waxman, Cancer Res., 50:5720-5726, 1990). The present study compares the effects of cyclophosphamide and its isomeric analogue ifosphamide on the gender-dependent expression of hepatic CYP 2C11 and steroid 5 alpha-reductase in adult male rats and also examines the role of
Waxman, Cancer Res., 50:5720-5726, 1990). The present study compares the effects of cyclophosphamide and its isomeric analogue ifosph
348 results
Jump to page
Feedback